Iminod 5% Cream
Product introduction
For genital warts, apply a thin layer of Iminod 5% Cream to the affected area at night, usually 3 times a week or as prescribed by your doctor. For actinic keratosis, use it as directed, typically for several weeks. Wash the area with soap and water before applying the medicine, and leave it on for the recommended duration (usually 6-10 hours). After that, wash the treated area thoroughly. Use it consistently for best results.
Some common side effects include redness, swelling, itching, or burning at the application site. These are usually mild and go away as your body adjusts to the medicine. If you experience severe irritation or signs of infection, such as pus or intense pain, discontinue use and consult your doctor. Using a moisturizer or barrier cream can help minimize discomfort caused by skin irritation.
Avoid applying Iminod 5% Cream on broken, irritated, or inflamed skin unless advised by your doctor. Limit sun exposure, as this medicine can make your skin more sensitive to UV rays, increasing the risk of sunburn. Wear sunscreen and protective clothing when outdoors. Pregnant or breastfeeding women should consult their doctor before using this medicine.
Uses of Iminod Cream
- Treatment of Actinic keratosis
- Treatment of Genital warts
Benefits of Iminod Cream
In Treatment of Actinic keratosis
In Treatment of Genital warts
Side effects of Iminod Cream
Common side effects of Iminod
- Itching
- Burning sensation
- Erythema (skin redness)
- Skin flakes
- Dry skin
- Application site swelling
- Skin exfoliation
- Skin ulcer
- Excoriation
How to use Iminod Cream
How Iminod Cream works
Safety advice
What if you forget to take Iminod Cream?
All substitutes
Quick tips
- Always wash and dry the affected area thoroughly before applying Iminod 5% Cream. This helps in better absorption and work more effectively.
- Apply the cream at night, usually 2-3 times a week, and leave it on for the recommended 6-10 hours. Wash it off in the morning with mild soap and water.
- If you experience skin irritation, redness, or dryness, consider using a mild, fragrance-free moisturizer to soothe the area.
- Iminod 5% Cream can make your skin more sensitive to sunlight. When using Iminod 5% Cream, avoid excessive sun exposure, and apply sunscreen or wear protective clothing outdoors to prevent sunburn.
- Refrain from sexual contact while on treatment with this medicine, as it may irritate your partner’s skin and weaken condoms and diaphragms, reducing their effectiveness.
- Stick to the prescribed application schedule. Do not skip or over apply the cream, as this may reduce its effectiveness or increase side effects.
Fact Box
Patient concerns
FAQs
What is Iminod 5% Cream used for?
How often should I apply Iminod 5% Cream for genital warts?
How long should I leave Iminod 5% Cream on before washing it off?
Can I have sexual contact while using Iminod 5% Cream?
Can I use Iminod 5% Cream on broken or irritated skin?
Can I use Iminod 5% Cream if I am pregnant or breastfeeding?
Does Iminod 5% Cream make my skin more sensitive to the sun?
How long does it take to see results with Iminod 5% Cream?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Robertson DB, Maibach HI. Dermatologic Pharmacology. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 1053.
- Burkhart C, Morrell D, Goldsmith L. Dermatological Pharmacology. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1823.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 6.98-99.